MEDICLINIC INTERNATIONAL LIMITED - Dealings In Securities By A Director And Company Secretary Of Mediclinic And By A Director Of A Major Subsidiary

Dealings In Securities By A Director And Company Secretary Of Mediclinic And By A Director Of A Major Subsidiary

MEDICLINIC INTERNATIONAL LIMITED
Incorporated in the Republic of South Africa
Registration number: 1983/010725/06
ISIN: ZAE0000074142
Share Code: MDC
(“Mediclinic” or “the Company”)

DEALINGS IN SECURITIES BY A DIRECTOR AND COMPANY SECRETARY OF
MEDICLINIC AND BY A DIRECTOR OF A MAJOR SUBSIDIARY

In compliance with the Listings Requirements of the JSE Limited,
the following persons, being a director of Mediclinic and the
company secretary of Mediclinic, disposed of a portion of their
rights by selling nil paid letters of allocation and elected to
follow the remaining portion of their rights to subscribe for new
Mediclinic shares, as detailed below, in terms of the rights offer
by Mediclinic, as announced on SENS on 24 August 2012 and 31
August 2012 and further detailed in the circular to shareholders
dated 17 September 2012.

In accordance with the salient dates relating to the rights offer
by Mediclinic, the rights offer shares will be issued on or about
Monday, 8 October 2012.

The rights offer by Mediclinic is in respect of 174 641 984 shares
made to shareholders in the ratio of 26.77263 new rights offer
shares for every 100 shares held at the close of trade on Friday,
14 September 2012 at a price of R28.63 per rights offer share.


Director                     :   Mr K H S Pretorius
Company                      :   Mediclinic International Limited
Date of transaction          :   20 September 2012
Nature of transaction        :   On market sale of letters of
                                 allocation in terms of rights offer
Number of securities         :   18 008
Class of securities          :   Letters of allocation in respect of
                                 ordinary shares offered in terms of
                                 rights offer
Selling price                :   12 473 @ R13.20 each
                                 5 535 @ R13.50 each
Total value of transaction   :   R239 366.10
Nature of interest           :   Direct beneficial

Director                     :   Mr K H S Pretorius
Company                      :   Mediclinic International Limited
Nature of transaction        :   Off market purchase of shares in
                                 terms of the rights offer
Number of securities         :   20 000
Class of securities          :   Ordinary shares offered in terms of
                                 the rights offer
Total value of transaction   :   R572 600.00
Nature of interest           :   Direct beneficial
Director                     :   Mr G C Hattingh (Company Secretary)
Company                      :   Mediclinic International Limited
Date of transaction          :   21 September 2012
Nature of transaction        :   On market sale of letters of
                                 allocation in terms of rights offer
Number of securities         :   2 686
Class of securities          :   Letters of allocation in respect of
                                 ordinary shares offered in terms of
                                 rights offer
Selling price                :   R13.19 each
Total value of transaction   :   R35 428.34
Nature of interest           :   Indirect beneficial

Director                     :   Mr G C Hattingh (Company Secretary)
Company                      :   Mediclinic International Limited
Nature of transaction        :   Off market purchase of shares in
                                 terms of the rights offer
Number of securities         :   29 559
Class of securities          :   Ordinary shares offered in terms of
                                 the rights offer
Total value of transaction   :   R846 274.17
Nature of interest           :   Indirect beneficial

The following director of a major subsidiary of Mediclinic
disposed of his rights by selling the nil paid letters of
allocation, as detailed below, pursuant to the rights offer by
Mediclinic.

Director                     :   Dr N S Matlala
Company                      :   Mediclinic Southern Africa (Pty)
                                 Ltd (major subsidiary of
                                 Mediclinic)
Date of transaction          :   21 September 2012
Nature of transaction        :   On market sale of letters of
                                 allocation in terms of rights offer
Number of securities         :   3 369
Class of securities          :   Letters of allocation in respect of
                                 ordinary shares offered in terms of
                                 rights offer
Selling price                :   R13.20 each
Total value of transaction   :   R44 470.80
Nature of interest           :   Direct beneficial

Clearance to deal was obtained for all the transactions mentioned
herein.

Stellenbosch
25 September 2012

Mediclinic Offices, Strand Road, Stellenbosch 7600, South Africa
PO Box 456, Stellenbosch 7599, South Africa
Tel +27 (0)21 809 6500
Fax +27 (0)21 886 4037
Ethics Line: 0800 005 316
Website: www.mediclinic.com

Sponsor
RAND MERCHANT BANK (A division of FirstRand Bank Limited)

Date: 25/09/2012 02:27:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.